Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 DeFi Kingdoms DeFi Kingdoms +1,084.27%
#4 Black Phoenix Black Phoenix +336.48%
#5 aPriori aPriori +113.53%
#6 Bedrock Bedrock +74.54%
#7 Cysic Cysic +46.36%
#8 Prom Prom +40.86%
#9 Playnance Playnance +34.97%
#10 COTI COTI +30.93%
Coin of the day
Wrapped One Wrapped One
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Rangering i aksjer #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Aksjekurs
$0.00023723
Sist synkronisert: 2024-08-26
Markedsverdi
$1.41K
Endring (1 dag)
111.67%
Endring (1 år)
0.00%
Land
FR
Handel Pharnext S.A. (ALPHA)

Kategori

Healthcare
EPS for Pharnext S.A. (ALPHA)
EPS per December 2023 TTM: $-77.35M
Ifølge de siste økonomiske rapportene og aksjekursen til Pharnext S.A. er selskapets nåværende EPS (TTM) $-77.35M. Ved slutten av 2022 hadde selskapet en EPS på $-11.16K, en nedgang sammenlignet med EPS-en i 2021 som var $-11.45K.
EPS-historikk for Pharnext S.A. fra 2013 til 2026
EPS ved slutten av hvert år
År EPS Endre
2026 (TTM) $-77.35M 35,598,509.46%
2023 $-217.28 -98.05%
2022 $-11.16K -2.49%
2021 $-11.45K 69.15%
2020 $-6.77K -21.06%
2019 $-8.57K -15.43%
2018 $-10.14K -100.00%
2017 $-6.00Qa 14.04%
2016 $-5.26Qa 44,068,612,420.18%
2015 $-11.94M -8.06%
2014 $-12.98M 1.29%
2013 $-12.82M 0.00%
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -100.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -100.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -100.00%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR